Almost every one of us has either been diagnosed ourselves or had a relative diagnosed with cancer. I’ve been lucky enough to stay cancer free, but I’ve had several people close to me ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...